(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 109.85%10.68M | ---- | -153.36%-108.36M | ---- | -207.95%-42.77M | ---- | 250.68%39.62M | ---- | -117.82%-26.3M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 29.90%-29.24M | ---- | 18.04%-41.71M | ---- | -562.47%-50.89M | ---- | -600.27%-7.68M | ---- | -12.28%-1.1M |
Attributable subsidiary (profit) loss | ---- | 68.03%4.63M | ---- | -49.40%2.76M | ---- | --5.45M | ---- | ---- | ---- | ---- |
Impairment and provisions: | ---- | -36.35%998K | ---- | -4.91%1.57M | ---- | -98.50%1.65M | ---- | 990.49%109.92M | ---- | 615.40%10.08M |
-Impairment of trade receivables (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 960.84%89.15M | ---- | --8.4M |
-Other impairments and provisions | ---- | -36.35%998K | ---- | -4.91%1.57M | ---- | -92.06%1.65M | ---- | 1,139.14%20.77M | ---- | 18.95%1.68M |
Revaluation surplus: | ---- | ---2.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---2.18M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | -8.02%4.29M | ---- | -1.48%4.66M | ---- | -16.89%4.73M | ---- | -14.44%5.69M | ---- | 175.34%6.66M |
-Depreciation | ---- | -34.88%364K | ---- | -18.39%559K | ---- | -54.67%685K | ---- | -35.76%1.51M | ---- | 3.16%2.35M |
-Amortization of intangible assets | ---- | -73.14%65K | ---- | 93.60%242K | ---- | 28.87%125K | ---- | -5.83%97K | ---- | -24.82%103K |
Financial expense | ---- | -12.53%39.64M | ---- | -15.74%45.32M | ---- | 318.68%53.78M | ---- | -21.74%12.85M | ---- | -16.31%16.41M |
Unrealized exchange loss (gain) | ---- | ---- | ---- | 84.40%-376K | ---- | -523.73%-2.41M | ---- | --569K | ---- | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | 100.95%3.09M | ---- | -6,471,320.00%-323.56M | ---- | --5K |
Operating profit before the change of operating capital | ---- | 129.97%28.81M | ---- | -251.25%-96.15M | ---- | 83.17%-27.37M | ---- | -2,921.82%-162.59M | ---- | -96.61%5.76M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | ---- | ---- | -96.06%1.48M | ---- | 200.98%37.57M | ---- | -232.80%-37.2M |
Accounts receivable (increase)decrease | ---- | -4.96%291.47M | ---- | 242.63%306.69M | ---- | 72.64%-215.03M | ---- | -422.30%-785.98M | ---- | -325.72%-150.49M |
Accounts payable increase (decrease) | ---- | 31.72%-241.15M | ---- | -243.05%-353.17M | ---- | -51.66%246.88M | ---- | 543.97%510.68M | ---- | -52.24%79.3M |
prepayments (increase)decrease | ---- | 149.89%63.72M | ---- | -48.89%-127.72M | ---- | -343.97%-85.78M | ---- | 118.52%35.16M | ---- | -1,507.41%-189.82M |
Special items for working capital changes | ---- | -371.09%-237.48M | ---- | 1,987.57%87.6M | ---- | -102.14%-4.64M | ---- | -20.36%216.85M | ---- | 190.29%272.28M |
Cash from business operations | ---- | 48.22%-94.62M | ---- | -116.38%-182.74M | 3.00%-133.31M | 43.06%-84.46M | 55.13%-137.43M | -635.67%-148.32M | -616.72%-306.29M | -231.15%-20.16M |
Other taxs | ---- | -22.71%-4.01M | ---- | 81.56%-3.27M | ---- | -281.62%-17.72M | ---- | 64.34%-4.64M | ---- | -37.35%-13.02M |
Special items of business | -1.75%21.6M | ---- | --21.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | -1.75%21.6M | 46.98%-98.63M | 116.49%21.98M | -82.06%-186.01M | 3.00%-133.31M | 33.20%-102.17M | 55.13%-137.43M | -361.00%-152.96M | -678.08%-306.29M | -663.04%-33.18M |
Cash flow from investment activities | ||||||||||
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 135.94%4.24M | ---- | 0.00%-11.79M | ---11.79M | ---11.79M |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.6M |
Purchase of fixed assets | -922.22%-92K | 96.13%-17K | 95.36%-9K | -16.45%-439K | -1,112.50%-194K | 15.85%-377K | 94.43%-16K | 15.63%-448K | -149.57%-287K | 98.09%-531K |
Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -3,762.50%-309K | ---73K | 75.76%-8K |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---22M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---78M | ---- | ---- | ---- | ---- | ---22M | ---- | ---- | ---- |
Net cash from investment operations | -922.22%-92K | -17,671.07%-78.02M | 95.36%-9K | 97.58%-439K | 99.12%-194K | -44.65%-18.14M | -81.26%-22.02M | -337.54%-12.54M | -121.24%-12.15M | 119.00%5.28M |
Net cash before financing | -2.13%21.51M | 5.26%-176.65M | 116.46%21.97M | -54.97%-186.45M | 16.27%-133.51M | 27.30%-120.31M | 49.93%-159.45M | -493.20%-165.5M | -389.02%-318.43M | -27.39%-27.9M |
Cash flow from financing activities | ||||||||||
New borrowing | -91.31%11.62M | -27.94%237.15M | -19.24%133.65M | 26.53%329.1M | 38.36%165.49M | -38.19%260.09M | -21.20%119.61M | 243.97%420.79M | 2,737.76%151.79M | -53.42%122.33M |
Refund | 79.17%-30.17M | 12.42%-176.47M | -140.10%-144.83M | 16.53%-201.5M | 47.67%-60.32M | 17.46%-241.42M | -118.78%-115.28M | -14.18%-292.48M | 52.17%-52.69M | 23.74%-256.17M |
Issuing shares | ---- | --87.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 694.73%508.96M |
Interest paid - financing | -27.54%-10.48M | -37.92%-7.27M | -31.50%-8.22M | 31.13%-5.27M | -13.70%-6.25M | -6.96%-7.65M | -14.30%-5.5M | 49.75%-7.16M | 90.15%-4.81M | 53.42%-14.24M |
Dividends paid - financing | --425K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---4.33M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---54.63M |
Pledged bank deposit (increase) decrease | -12.25%10.2M | -15.21%19.47M | -49.06%11.63M | 299.66%22.96M | 1,268.65%22.83M | 28.23%-11.5M | 109.39%1.67M | 56.69%-16.02M | -283.06%-17.77M | -276.93%-37M |
Other items of the financing business | 120.34%390K | -107.20%-55K | 7.27%177K | 22.04%764K | -76.22%165K | -67.41%626K | -83.70%694K | 92.87%1.92M | 933.50%4.26M | 129.95%996K |
Adjustment item of financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---- | ---- |
Net cash from financing operations | -137.24%-18.02M | 7.32%152.4M | -106.23%-7.6M | 3,926.65%142.01M | 10,093.39%121.91M | -103.60%-3.71M | -98.52%1.2M | -61.19%103.19M | 160.36%80.78M | 1,297.82%265.85M |
Net Cash | -75.75%3.49M | 45.44%-24.25M | 224.02%14.38M | 64.17%-44.44M | 92.67%-11.59M | -99.02%-124.02M | 33.41%-158.25M | -126.19%-62.32M | -905.31%-237.66M | 639.62%237.95M |
Begining period cash | -137.01%-6.55M | -71.52%17.7M | -71.52%17.7M | -66.62%62.14M | -66.62%62.14M | -25.08%186.16M | -30.25%186.16M | 2,258.61%248.48M | 2,433.46%266.9M | -80.72%10.54M |
Items Period | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- |
Cash at the end | -109.55%-3.06M | -137.01%-6.55M | -36.54%32.08M | -71.52%17.7M | 81.09%50.55M | -66.62%62.14M | -4.56%27.91M | -25.08%186.16M | 323.16%29.25M | 2,258.61%248.48M |
Cash balance analysis | ||||||||||
Cash and bank balance | -43.59%80.94M | -25.56%96.56M | --143.49M | -31.19%129.72M | ---- | --188.51M | ---- | ---- | ---- | ---- |
Cash and cash equivalent balance | -43.59%80.94M | -25.56%96.56M | --143.49M | -31.19%129.72M | ---- | --188.51M | ---- | ---- | ---- | ---- |
Currency Unit | THP | THP | THP | THP | THP | THP | THP | THP | THP | THP |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Yongtuo Fuxin Certified Public Accountants Co., Ltd. | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data